Skip to main content

Table 3 Cox regression analysis of recurrence free- and overall survival in ER positive patients

From: Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer

 

BCSS

 

OS

 

ER Positive (n = 285)

HR (95% CI)

p

HR (95% CI)

p

SNAS

Univariate

 

Univariate

 

low

1

 

1

 

high

2.01(1.14 - 3.54)

0.014

1.57(1.14 - 2.16)

0.005

SNAS

Multivariate

 

Multivariate

 

low

1

 

1

 

high

1.38(0.71 - 2.66)

0.335

1.36(0.90 - 2.06)

0.140

SNAS

Multivariate + treatment adjusted

 

Multivariate + treatment adjusted

 

low

1

 

1

 

high

1.87(0.71 - 4.88)

0.194

1.92(0.98 - 3.78)

0.055

CNR

Univariate

 

Univariate

 

low

1

 

1

 

high

0.52(0.29 - 0.94)

0.032

0.85(0.61 - 1.13)

0.320

CNR

Multivariate

 

Multivariate

 

low

1

 

1

 

high

0.805(0.52 - 1.22)

0.315

0.54(0.27 - 1.10)

0.094

CNR

Multivariate + treatment adjusted

 

Multivariate + treatment adjusted

 

low

1

 

1

 

high

0.41(0.15 - 1.13)

0.087

0.44(0.23 - 0.87)

0.018

  1. * Multivariate analysis included adjustment for grade, age, nodal status, PR status, Her2 and tumour size